For the quarter ended March 2025, Credit Acceptance (CACC) reported revenue of $571.1 million, up 12.4% over the same period last year. EPS came in at $8.66, compared to $5.08 in the year-ago quarter. The reported revenue represents a surprise of +0.79% over the Zacks Consensus Estimate of $566.6 million. With the consensus EPS estimate being $10.31, the EPS surprise was -16.00%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Credit Acceptance performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Finance charges: $526.70 million compared to the $521.73 million average estimate based on two analysts. The reported number represents a change of +12.3% year over year. Revenue- Other income: $20.90 million versus the two-analyst average estimate of $19.59 million. The reported number represents a year-over-year change of +23.7%. Revenue- Premiums earned: $23.50 million compared to the $25.29 million average estimate based on two analysts. The reported number represents a change of +7.3% year over year. View all Key Company Metrics for Credit Acceptance here>>> Shares of Credit Acceptance have returned -6.6% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Credit Acceptance Corporation (CACC):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Compared to Estimates, Credit Acceptance (CACC) Q1 Earnings: A Look at Key Metrics
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...